<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39446912</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Kidney replacement therapy in COVID-19-Related acute kidney injury: The impact of timing on mortality.</ArticleTitle><Pagination><StartPage>e0309655</StartPage><MedlinePgn>e0309655</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0309655</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0309655</ELocationID><Abstract><AbstractText>The objective of this study was to determine the impact of the timing of KRT, dichotomized by a temporal criterion or by creatinine level, in patients with COVID-19-related AKI. This was a retrospective study involving 512 adult patients admitted to the ICU. All participants had laboratory-confirmed COVID-19 and a confirmed diagnosis of AKI. The potential predictors were the determination of the timing of KRT based on a temporal criterion (days since hospital admission) and that based on a serum creatinine cutoff criterion. Covariates included age, sex, and the SOFA score, as well as the need for mechanical ventilation and vasopressors. The main outcome measure was in-hospital mortality. We evaluated 512 patients, of whom 69.1% were men. The median age was 64 years. Of the 512 patients, 76.6% required dialysis after admission. The overall in-hospital mortality rate was 72.5%. When the timing of KRT was determined by the temporal criterion, the risk of in-hospital mortality was significantly higher for later KRT than for earlier KRT-84% higher in the univariate analysis (OR = 1.84, 95%, [CI]: 1.10-3.09) and 140% higher after adjustment for age, sex, and SOFA score (OR = 2.40, 95% CI: 1.36-4.24). When it was determined by the creatinine cutoff criterion, there was no such difference between high and low creatinine at KRT initiation. In patients with COVID-19-related AKI, earlier KRT might be associated with lower in-hospital mortality.</AbstractText><CopyrightInformation>Copyright: © 2024 de Almeida et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Almeida</LastName><ForeName>Carlos Augusto Pereira</ForeName><Initials>CAP</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Marcia Fernanda Arantes</ForeName><Initials>MFA</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Alexandre Macedo</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Carla Paulina Sandoval</ForeName><Initials>CPS</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smolentzov</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reichert</LastName><ForeName>Bernardo Vergara</ForeName><Initials>BV</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gessolo Lins</LastName><ForeName>Paulo Ricardo</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Camila Eleuterio</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seabra</LastName><ForeName>Victor Faria</ForeName><Initials>VF</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3078-8957</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have read the journal’s policy and have the following competing interests: CAPdA is a member of the Global Medical Review team at Eli Lilly and Company (https://www.lilly.com/). PRGL started working at Baxter Brasil in June/2023. VFS received a consulting fee for participation on an Advisory Board meeting in March 2022 for Vifor Pharma Brazil (https://www.cslvifor.com.br/) outside of the submitted work. CER received fees from Medtronic for providing instruction in catheter insertion in 2021 outside of the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39446912</ArticleId><ArticleId IdType="pmc">PMC11500876</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0309655</ArticleId><ArticleId IdType="pii">PONE-D-24-08820</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burki T. COVID-19 in Latin America. Lancet Infect Dis. 2020;20(5):547–548. doi: 10.1016/S1473-3099(20)30303-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30303-0</ArticleId><ArticleId IdType="pmc">PMC7164892</ArticleId><ArticleId IdType="pubmed">32311323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministério da Saúde (BR). Saúde Brasil 2020/2021: uma análise da situação de saúde diante da pandemia de covid19, doença causada pelo coronavírus SARS-CoV-2. Brasília: Ministério da Saúde; 2022.</Citation></Reference><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19) dashboard. Accessed October 17, 2022. https://covid19.who.int</Citation></Reference><Reference><Citation>Secretarias Estaduais de Saúde. Brasil, 2020, 2021, 2022 e 2023.
Coronavírus (COVID-19) no Brasil. Accessed October 17, 2022. https://infoms.saude.gov.br/extensions/covid-19_html/covid-19_html.html</Citation></Reference><Reference><Citation>Li X, Ma X. Acute respiratory failure in COVID-19: Is it “typical” ARDS? Crit Care. 2020;24(1). doi: 10.1186/s13054-020-02911-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02911-9</ArticleId><ArticleId IdType="pmc">PMC7202792</ArticleId><ArticleId IdType="pubmed">32375845</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, et al.. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi: 10.1001/jamainternmed.2020.0994</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu KH, Tsang WK, Tang CS, et al.. Acute Renal Impairment in Coronavirus-Associated Severe Acute Respiratory Syndrome. Kidney Int. 2005;67(2):698–705. doi: 10.1111/j.1523-1755.2005.67130.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.67130.x</ArticleId><ArticleId IdType="pmc">PMC7112337</ArticleId><ArticleId IdType="pubmed">15673319</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhri I, Moffitt R, Taub E, et al.. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Press Res. 2020;11716:1–15. doi: 10.1159/000511946</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511946</ArticleId><ArticleId IdType="pubmed">33171466</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al.. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417–1418. doi: 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Li X, Chen H, et al.. Coronavirus disease 19 infection does not result in acute kidney injury: An analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol. 2020;51(5):343–348. doi: 10.1159/000507471</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507471</ArticleId><ArticleId IdType="pmc">PMC7179524</ArticleId><ArticleId IdType="pubmed">32229732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, et al.. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. The BMJ. 2020;368. doi: 10.1136/bmj.m1091</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha RH, Joh JS, Jeong I, et al.. Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital. J Korean Med Sci. 2015;30(12):1807–1814. doi: 10.3346/jkms.2015.30.12.1807</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2015.30.12.1807</ArticleId><ArticleId IdType="pmc">PMC4689825</ArticleId><ArticleId IdType="pubmed">26713056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, et al.. AKI in hospitalized patients with COVID-19. Journal of the American Society of Nephrology. 2021;32(1):151–160. doi: 10.1681/ASN.2020050615</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050615</ArticleId><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S, Nie S, Liu Z, et al.. Epidemiology and outcomes of acute kidney injury in elderly Chinese patients: A subgroup analysis from the EACH study. BMC Nephrol. 2016;17(1). doi: 10.1186/s12882-016-0351-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-016-0351-2</ArticleId><ArticleId IdType="pmc">PMC5041437</ArticleId><ArticleId IdType="pubmed">27682843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco Claudio; Reis Thiago; Husain-Syed Faeq. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;(July):738–742. doi: 10.1016/S2213-2600(20)30229-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30229-0</ArticleId><ArticleId IdType="pmc">PMC7255232</ArticleId><ArticleId IdType="pubmed">32416769</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al.. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA—Journal of the American Medical Association. 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi R, Ferreiro A, Ponce D, et al.. Latin American registry of renal involvement in COVID-19 disease. The relevance of assessing proteinuria throughout the clinical course. PLoS One. 2022;17(1 January). doi: 10.1371/journal.pone.0261764</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261764</ArticleId><ArticleId IdType="pmc">PMC8794101</ArticleId><ArticleId IdType="pubmed">35085273</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaan F, de Paula EC, de Lima Souza FBG, et al.. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in São Paulo, Brazil. PLoS One. 2022;17(1 January 2022). doi: 10.1371/journal.pone.0261958</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261958</ArticleId><ArticleId IdType="pmc">PMC8759670</ArticleId><ArticleId IdType="pubmed">35030179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudry S, Hajage D, Schortgen F, et al.. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. New England Journal of Medicine. 2016;375(2):122–133. doi: 10.1056/NEJMoa1603017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603017</ArticleId><ArticleId IdType="pubmed">27181456</ArticleId></ArticleIdList></Reference><Reference><Citation>STARRT-AKI Investigators, Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group; Bagshaw SM, et al..: Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
New England Journal of Medicine. 383: 240–251, 2020. Available from: http://www.nejm.org/doi/10.1056/NEJMoa2000741o 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2000741</ArticleId><ArticleId IdType="pubmed">32668114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu C, Mao Z, Li Q, Zhou F. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Crit Care. 2021;25(1). doi: 10.1186/s13054-020-03451-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03451-y</ArticleId><ArticleId IdType="pmc">PMC7789484</ArticleId><ArticleId IdType="pubmed">33407756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudry S, Hajage D, Benichou N, et al.. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020;395(10235):1506–1515. doi: 10.1016/S0140-6736(20)30531-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30531-6</ArticleId><ArticleId IdType="pubmed">32334654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Kellum JA, Schmidt C, et al.. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The elain randomized clinical trial. JAMA—Journal of the American Medical Association. 2016;315(20):2190–2199. doi: 10.1001/jama.2016.5828</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.5828</ArticleId><ArticleId IdType="pubmed">27209269</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudry S, Hajage D, Martin-Lefevre L, et al.. Comparison of Two Delayed Strategies for Renal Replacement Therapy Initiation for Severe Acute Kidney Injury (AKIKI 2): A Multicentre, Open-Label, Randomised, Controlled Trial. Vol 397.; 2021. www.thelancet.com</Citation><ArticleIdList><ArticleId IdType="pubmed">33812488</ArticleId></ArticleIdList></Reference><Reference><Citation>Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of Renal Replacement Therapy Initiation in Acute Renal Failure: A Meta-analysis. American Journal of Kidney Diseases. 2008;52(2):272–284. doi: 10.1053/j.ajkd.2008.02.371</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.02.371</ArticleId><ArticleId IdType="pubmed">18562058</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade L, Cleto S, Seguro AC. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: Impact on mortality. Clinical Journal of the American Society of Nephrology. 2007;2(4):739–744. doi: 10.2215/CJN.00680207</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00680207</ArticleId><ArticleId IdType="pubmed">17699490</ArticleId></ArticleIdList></Reference><Reference><Citation>Worldometers. World-population. Accessed June 17, 2023. https://www.worldometers.info/world-population/</Citation></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al.. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl (2011). 2012;2(1):1–138. doi: 10.1038/kisup.2012.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Inker LA, Eneanya ND, Coresh J, et al.. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. New England Journal of Medicine. 2021;385(19):1737–1749. doi: 10.1056/NEJMoa2102953</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2102953</ArticleId><ArticleId IdType="pmc">PMC8822996</ArticleId><ArticleId IdType="pubmed">34554658</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado C, Baweja M, Crews DC, et al.. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. American Journal of Kidney Diseases. 2022;79(2):268–288.e1. doi: 10.1053/j.ajkd.2021.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2021.08.003</ArticleId><ArticleId IdType="pubmed">34563581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, et al.. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7110296</ArticleId><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang X, et al.. The incidence, risk factors, and prognosis of acute kidney injury in adult patients with coronavirus disease 2019. Clinical Journal of the American Society of Nephrology. 2020;15(10):1394–1402. doi: 10.2215/CJN.04650420</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04650420</ArticleId><ArticleId IdType="pmc">PMC7536762</ArticleId><ArticleId IdType="pubmed">32963018</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch Jamie S., Ng Jia H., Ross Daniel W., Sharma Purva, Shah Hitesh H., Barnett Richard L., et al.. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. Published online 2020:209–218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229463</ArticleId><ArticleId IdType="pubmed">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick MR, Hilburg R. Acute Kidney Injury in COVID-19: Another Challenge for Nephrology. Am J Nephrol. 2020;51(10):761–763. doi: 10.1159/000511161</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511161</ArticleId><ArticleId IdType="pmc">PMC7649678</ArticleId><ArticleId IdType="pubmed">33059350</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson KE, Campoccia-Jalde F, Rysz S, Rimes-Stigare C. Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery. J Crit Care. 2021;64:125–130. doi: 10.1016/j.jcrc.2021.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.04.002</ArticleId><ArticleId IdType="pmc">PMC8052481</ArticleId><ArticleId IdType="pubmed">33878517</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher R, Clarke J, Al-Arfi K, et al.. Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre. J Crit Care. 2021;62:190–196. doi: 10.1016/j.jcrc.2020.12.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2020.12.023</ArticleId><ArticleId IdType="pmc">PMC7837302</ArticleId><ArticleId IdType="pubmed">33422809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kant S, Menez SP, Hanouneh M, et al.. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol. 2020;21(1). doi: 10.1186/s12882-020-02112-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-020-02112-0</ArticleId><ArticleId IdType="pmc">PMC7590240</ArticleId><ArticleId IdType="pubmed">33109103</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bell S, Forni L, et al.. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751–764. doi: 10.1038/s41581-021-00452-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00452-0</ArticleId><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17(1):46–64. doi: 10.1038/s41581-020-00357-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00357-4</ArticleId><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Volbeda M, Jou-Valencia D, van den Heuvel MC, et al.. Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients. Crit Care. 2021;25(1). doi: 10.1186/s13054-021-03631-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03631-4</ArticleId><ArticleId IdType="pmc">PMC8190989</ArticleId><ArticleId IdType="pubmed">34112226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald R, Beaubien-Souligny W, Chanchlani R, et al.. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Intensive Care Med. 2022;48(10):1368–1381. doi: 10.1007/s00134-022-06851-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06851-6</ArticleId><ArticleId IdType="pubmed">36066597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. The Lancet. 2019;394(10212):1949–1964. doi: 10.1016/S0140-6736(19)32563-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa S, Samoni S, Ronco C. Creatinine-based definitions: From baseline creatinine to serum creatinine adjustment in intensive care. Crit Care. 2016;20(1). doi: 10.1186/s13054-016-1218-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1218-4</ArticleId><ArticleId IdType="pmc">PMC4794949</ArticleId><ArticleId IdType="pubmed">26983854</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SJ, Brandtner AK, Lehner GF, et al.. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018;44(3):323–336. doi: 10.1007/s00134-018-5126-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5126-8</ArticleId><ArticleId IdType="pmc">PMC5861176</ArticleId><ArticleId IdType="pubmed">29541790</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Mansour SG. Perspective on clinical application of biomarkers in AKI. Journal of the American Society of Nephrology. 2017;28(6):1677–1685. doi: 10.1681/ASN.2016101127</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016101127</ArticleId><ArticleId IdType="pmc">PMC5461806</ArticleId><ArticleId IdType="pubmed">28220028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Zarbock A, Goldstein S, et al.. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw Open. 2020;3(10):E2019209. doi: 10.1001/jamanetworkopen.2020.19209</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19209</ArticleId><ArticleId IdType="pubmed">33021646</ArticleId></ArticleIdList></Reference><Reference><Citation>Canney M, Clark EG, Hiremath S. Biomarkers in acute kidney injury: On the cusp of a new era? Journal of Clinical Investigation. 2023;133(13). doi: 10.1172/JCI171431</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI171431</ArticleId><ArticleId IdType="pmc">PMC10313371</ArticleId><ArticleId IdType="pubmed">37395275</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: Perspectives on translation. Clinical Journal of the American Society of Nephrology. 2008;3(2):481–490. doi: 10.2215/CJN.03520807</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.03520807</ArticleId><ArticleId IdType="pmc">PMC6631074</ArticleId><ArticleId IdType="pubmed">18256377</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Yuen PS, Eisner C, et al.. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. Journal of the American Society of Nephrology. 2009;20(6):1217–1221. doi: 10.1681/ASN.2008060617</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008060617</ArticleId><ArticleId IdType="pmc">PMC2689892</ArticleId><ArticleId IdType="pubmed">19389851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard J, Soroko SB, Chertow GM, et al.. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422–427. doi: 10.1038/ki.2009.159</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2009.159</ArticleId><ArticleId IdType="pubmed">19436332</ArticleId></ArticleIdList></Reference><Reference><Citation>Messmer AS, Zingg C, Müller M, Gerber JL, Schefold JC, Pfortmueller CA. Fluid Overload and Mortality in Adult Critical Care Patients-A Systematic Review and Meta-Analysis of Observational Studies*. Crit Care Med. 2020;48(12):1862–1870. doi: 10.1097/CCM.0000000000004617</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004617</ArticleId><ArticleId IdType="pubmed">33009098</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain-Syed F, Ricci Z, Brodie D, et al.. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk. Intensive Care Med. 2018;44(9):1447–1459. doi: 10.1007/s00134-018-5329-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5329-z</ArticleId><ArticleId IdType="pubmed">30043276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bagshaw SM, Bellomo R, et al.. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation. Blood Purif. 2021;50(1):17–27. doi: 10.1159/000508125</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508125</ArticleId><ArticleId IdType="pmc">PMC7270067</ArticleId><ArticleId IdType="pubmed">32454500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Navalesi P, Vincent JL. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Lancet Respir Med. 2020;8(3):240–241. doi: 10.1016/S2213-2600(20)30060-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30060-6</ArticleId><ArticleId IdType="pmc">PMC7154507</ArticleId><ArticleId IdType="pubmed">32035509</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020;8(5):433–434. doi: 10.1016/S2213-2600(20)30127-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30127-2</ArticleId><ArticleId IdType="pmc">PMC7118607</ArticleId><ArticleId IdType="pubmed">32203709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Joannidis M, Pani A, et al.. Patient Selection and Timing of Continuous Renal Replacement Therapy. Blood Purif. 2016;42(3):224–237. doi: 10.1159/000448506</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000448506</ArticleId><ArticleId IdType="pubmed">27561956</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Clark WR, Ricci Z, Ronco C. Renal replacement therapy for AKI: When? How much? When to stop? Best Pract Res Clin Anaesthesiol. 2017;31(3):371–385. doi: 10.1016/j.bpa.2017.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2017.10.001</ArticleId><ArticleId IdType="pubmed">29248144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard J, Mehta RL. Timing of Kidney Support Therapy in Acute Kidney Injury: What Are We Waiting For? American Journal of Kidney Diseases. 2022;79(3):417–426. doi: 10.1053/j.ajkd.2021.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2021.07.014</ArticleId><ArticleId IdType="pubmed">34461167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chander S, Luhana S, Sadarat F, et al.. Mortality and mode of dialysis: meta-analysis and systematic review. BMC Nephrol. 2024;25(1). doi: 10.1186/s12882-023-03435-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-023-03435-4</ArticleId><ArticleId IdType="pmc">PMC10763097</ArticleId><ArticleId IdType="pubmed">38172835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Liu F, Tao W, Qian K. Timing of renal replacement therapy in patients with sepsis-associated acute kidney injury: A systematic review and meta-analysis. Australian Critical Care. 2024;37(2):369–379. doi: 10.1016/j.aucc.2023.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aucc.2023.06.011</ArticleId><ArticleId IdType="pubmed">37734999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>